RecallHawk

METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE)

AMNEAL

Summary

FDA approved METHYLPREDNISOLONE SODIUM SUCCINATE (METHYLPREDNISOLONE) by AMNEAL. ANDA (Generic) approval (Labeling) on 2026-06-25. INJECTABLE, INJECTION.

Details

Source

Drug Approval

External ID

ANDA207549-21

Action Date

2026-06-25

Status

Approved

Category

drug

Product Code

ANDA (Generic)

Product Description

METHYLPREDNISOLONE SODIUM SUCCINATE (generic: METHYLPREDNISOLONE), INJECTABLE, INJECTION. Application: ANDA207549

Company

Context & Analysis

AMNEAL has 70 FDA actions in our database.

Frequently Asked Questions

How often does AMNEAL have FDA actions?

AMNEAL has 70 FDA actions in our database, including 0 recalls and 0 device clearances.

Where can I find the official FDA record?

The official record is available on FDA.gov. Search for "ANDA207549-21" on FDA.gov for the full record. You can also use the openFDA API to query this record programmatically.

Want to know the moment something like this happens?

Get alerts for drug

Related Actions